Inovio Pharmaceuticals Inc
INO
$1.29+4.03%
End of day · as of Sep 23, 2026, 4:02 AM ET
Mkt cap
$88.03M
EV/Sales
669.7
P/E ratio
N/A
FY2025 Revenue
$65,343
EPS (TTM)
$-1.03
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-130000.00%
Beta
1.44
Div yield
N/A
Sector
Healthcare
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Latest reported INO revenue for 2025-12-31 was $65.3K. Net income was -$84.9M. Revenue was down 70.0% from 2024-12-31 to 2025-12-31. INO currently screens at market cap $88.0M.
Use this INO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full INO income, balance, and cash tables.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company in the Healthcare sector.
Latest cached Inovio Pharmaceuticals Inc (INO) revenue for Dec 31, 2025 was $65.3K. Net income was -$84.9M. Statements: https://lician.com/financials/ino
Inovio Pharmaceuticals Inc (INO) market capitalization is $88.0M on the latest cached snapshot.
Inovio Pharmaceuticals Inc (INO) cached previous close $1.24; day range $1.25 – $1.34; volume 2,872,619. Session quote: https://lician.com/quote/ino
Inovio Pharmaceuticals Inc (INO) latest cached earnings event is "INO earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached INO filing is 8-K · Jul 31, 2026. Filings: https://lician.com/sec/ino